Skip to Main Content

Paper Details

Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma.
J Allergy Clin Immunol Pract
16
2023
Author NameAffiliation
William W BusseUniversity of Wisconsin School of Medicine and Public Health
  • 1 - 1

Datasets

Release 1.2